Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas
Zhejiang DTRM Biopharma
Zhejiang DTRM Biopharma
Oncternal Therapeutics, Inc
Celgene
miRagen Therapeutics, Inc.
Fondazione Italiana Linfomi - ETS
miRagen Therapeutics, Inc.
Seagen Inc.
Seagen Inc.
Seagen Inc.
Ariad Pharmaceuticals
National Cancer Institute (NCI)